Clinical Trial Update: A Study of the Efficacy and Safety of Topiramate in the Treatment of Patients With Epilepsy. [Phase 2]

View source ↗

Summary

Phase 2 clinical trial assessing the efficacy and safety of Topiramate in patients with epilepsy, including partial seizures; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy
• Partial Seizures

Drugs mentioned

• Topiramate (Topiramate)

Snippet

Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Conditions: Epilepsy, Epilepsies, Partial | Phase 2 | Status: COMPLETED